Insider Transactions in Q2 2021 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,794
-47.74%
|
$11,176
$4.37 P/Share
|
|
Jun 01
2021
|
Lawrence M Alleva Director |
BUY
Open market or private purchase
|
Indirect |
12,600
+50.0%
|
$0
$0.79 P/Share
|